Dabur India Q4 FY26: Growth holds, margin risks rise

Shares under pressure as risks stack up

Dabur India’s shares have stayed under pressure as investors balance a steady domestic recovery against uncertainty in overseas markets and input costs. The stock has fallen over 17% since the start of the Iran war, with the West Asian crisis emerging as a near-term swing factor for sentiment. Alongside geopolitics, the market is also tracking concerns around a weak monsoon and what that could mean for rural demand. Brokerages have remained cautious, not because growth is absent, but because visibility on margins and international revenues has weakened.

A key debate highlighted is whether Dabur can protect operating performance when two moving parts are under stress at the same time: costs and international disruptions. The company’s India business is showing improvement sequentially, but international operations, particularly in West Asia, are facing headwinds. That divergence has become central to how the market is valuing the stock in the short run.

Q4 FY26 trading update: mid-single digit topline growth

In its Q4 FY26 (January to March) trading update, Dabur indicated consolidated revenues grew in mid-single digits. The company also said operating profit is expected to grow ahead of revenue, suggesting cost control and mix may be helping profitability despite broader pressures. This update signalled continued growth, but it also underlined that the performance is uneven across geographies.

Within India, management commentary described a sequential recovery in demand, with the India FMCG business expected to deliver high single-digit growth for the quarter. But the international business faced disruption in West Asia, limiting consolidated momentum. The market’s immediate focus has therefore shifted from pure growth to the quality and durability of growth across segments.

Domestic demand: sequential recovery, but monsoon sensitivity remains

Dabur said consumption trends improved sequentially in its India FMCG business, supporting its expectation of a progressive recovery in domestic demand. The update positions the domestic portfolio as resilient despite macro uncertainty, but it also acknowledges that rural demand remains an overhang. The article flags monsoon uncertainty as a key variable that can swing rural consumption, affecting volume-led growth expectations.

This matters because Dabur’s near-term narrative depends on domestic recovery continuing while the international business deals with disruptions. If rural demand weakens due to a poor monsoon, the company may have to lean more on pricing and cost actions, both of which can have implications for competitiveness and margins.

Segment view: Home and Personal Care leads

The article breaks out the expected segment trends for Q4 FY26:

• Home and Personal Care was expected to grow in the mid-teens, driven by hair oils, shampoo, and home care.
• Healthcare was expected to post low single-digit growth, reflecting mixed performance.
• Food and Beverages was expected to record low single-digit growth, with sequential improvement.

A specific drag mentioned was Dabur Glucose, which was impacted by unseasonal rains in key markets during March. That weather disruption weighed on performance and contributed to the expectation of low single-digit growth for the healthcare business for the quarter.

International business: West Asia disruption offsets strength elsewhere

International operations were described as facing significant headwinds, particularly in West Asia, due to the impact of the US-Israel-Iran conflict. Even with other markets performing well, the West Asia disruption is material because it affects both demand and supply chain conditions.

The article notes that Turkey, Bangladesh, and the UK performed well with double-digit growth in constant currency terms. However, despite those pockets of strength, Dabur expected the overall international business to deliver low single-digit growth in INR terms. This gap between constant-currency momentum and reported INR growth is an important point for investors assessing how much international operations can contribute in the near term.

Brokerage stance: Morgan Stanley stays Underweight

Morgan Stanley maintained an Underweight rating on Dabur India with a target price of ₹412. The brokerage acknowledged Q4 FY26 performance indicators such as mid-single digit revenue growth and EBITDA growth of approximately 6% year-on-year, but flagged Middle East disruptions as a key risk for international operations.

Separately, the article includes a portfolio action note stating, “We have exited Dabur”, where the stock had a 5% weight in the Diwali and Budget portfolios. Together, these points show how geopolitical risk and demand uncertainty are influencing positioning, even as the domestic business shows sequential improvement.

Key data points mentioned

What investors are watching next

The article frames the key issue as visibility rather than the existence of growth. In India, monsoon developments and rural demand trends remain central, because they influence both volumes and the scope for pricing actions. Internationally, conditions in West Asia are positioned as the primary swing factor, given the demand and supply chain constraints described.

Input costs were also highlighted as rising, keeping attention on whether operating profit can continue to outpace revenue without hurting competitiveness. The company said it is monitoring geopolitical developments and taking proactive measures to mitigate risks to operations and cost structures.

Conclusion

Dabur’s Q4 FY26 update points to continued growth and a sequential recovery in India, led by stronger performance in Home and Personal Care. But the stock’s weakness reflects uncertainty around rural demand due to monsoon risk and disruption in West Asia affecting international momentum. The next major catalyst is the April 30, 2026 results and any management commentary on international normalisation, cost trends, and the pace of domestic demand recovery.